| [NT 15003449]: |
Chapter 1_Fundamentals of targeted drug delivery -- Chapter 2_Influence of drug properties and routes of drug administration on design of sustained and controlled release systems -- Chapter 3_Polymeric materials in controlled drug delivery -- Chapter 4_Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems -- Chapter 5_Parenteral drug delivery -- Chapter 6_Proteins / peptides drug delivery systems -- Chapter 7_Transdermal / skin drug delivery system -- Chapter 8_Implantable Therapeutics Systems -- Chapter 9_Chemical drug delivery systems -- Chapter 10_Targeted brain delivery -- Chapter 11_Targeted Tumor Delivery -- Chapter 12_Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting -- Chapter 13_Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes -- Chapter 14_Controlled release formulations for alternate routes of administration -- Chapter 15_Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems -- Chapter 16_Role of controlled release in veterinary formulations -- Chapter 17_Colloidal drug delivery systems: (a) Liposomes and niosomes -- Chapter 18_Solid lipid nanoparticles and nanostructured lipid carriers -- Chapter 19_Polymeric nanoparticles - PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes -- Chapter 20_Theranostics Application of Controlled Release Drug Delivery systems -- Chapter 21_Regulatory approval pathways involved in controlled release formulations. |